P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH...
Buti, M.;Morillas, R.;Manzano, M.L.;García-Retortillo, M.;Gutiérrez, M.L.;Martín, L.;Prieto, M.;Suárez, E.;Gea, F.;Rodríguez, M.;Zozaya, J.M.;López, J.;Gómez, M.;Simón, M.Á.;Morano, L.E.;Pardo, A.;Esteban, R.;
2014-04-01 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngJournal of HepatologyCrossRefhttp://www.deepdyve.com/lp/crossref/p1040-tenofovir-for-the-prophylaxis-of-hbv-reactivation-in-anti-hbc-5UGatI5OcQ
P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.